Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
This report contains market size and forecasts of Phage Therapy in Global, including the following market information:
Global Phage Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Phage Therapy market was valued at 33 million in 2021 and is projected to reach US$ 97.9 million by 2028, at a CAGR of 16.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DsDNA Bacteriophage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Phage Therapy include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Phage Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phage Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Phage Therapy Market Segment Percentages, by Type, 2021 (%)
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Global Phage Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Phage Therapy Market Segment Percentages, by Application, 2021 (%)
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Global Phage Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Phage Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Phage Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Phage Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage

LEAVE A REPLY

Please enter your comment!
Please enter your name here